Joshua Cohen covers healthcare policy, with a special focus on prescription drug pricing and reimbursement. Cohen writes about a wide variety of topics, including weight loss drugs, the Inflation Reduction Act, and even things like health risks related to climate change.
The Food and Drug Administration approved neffy for the emergency treatment of type I allergic reaction s, including those that can be life-threatening , in adult and pediatric patients who weigh at least 30 kilograms , according to apublished August 9th. Availability of an easier to administer epinephrine-based nasal spray may reduce barriers to rapid treatment of anaphylaxis, especially for those people have a fear of needles or injections.
The most common side effects of neffy reported in clinical studies were throat irritation , headache and nasal discomfort .neffy despite a positive recommendation from an expert panel of advisors. The agency requested that the manufacturer complete a study comparing repeat doses of neffy to those of epinephrine injections, which is what the sponsor did prior to last week’s approval.
Anaphylaxis is the most severe form of reaction and constitutes a medical emergency because it can result in sudden, life-threatening respiratory failure. People with anaphylaxis can experience extreme difficulty breathing, swelling, low blood pressure, bluish skin and shock. The condition is responsible for more than 30,000 emergency room visits annually and results in approximately 2,000 hospitalizations and 230 deaths in the U.S. each year.
Epinephrine Neffy Nasal Spray Allergic Reaction Anaphylaxis Insurance Coverage Pricing And Reimbursement
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves neffy nasal spray as alternative to EpiPenNeffy is the first needle-free alternative to shots like EpiPen.
Read more »
FDA approves first nasal spray to treat dangerous allergic reactionsU.S. health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen.
Read more »
First-Ever Nasal Spray for Life-Threatening Allergic Reactions ApprovedThe epinephrine nasal spray Neffy, a needle-free alternative to the EpiPen, is approved to treat emergency anaphylaxis. Here's the latest.
Read more »
Nasal spray alternative to EpiPen for allergic reactions is approved by FDANeffy is expected to be available in the United States within eight weeks of FDA approval, the company said.
Read more »
FDA Approves First Nasal Spray for Allergic ReactionsAn epinephrine nasal spray to treat serious allergic reactions may soon be available in the United States.
Read more »
FDA approves first nasal spray for anaphylaxis as alternative to EpiPenReuters
Read more »